Literature DB >> 28371217

Inherited germline ATRX mutation in two brothers with ATR-X syndrome and osteosarcoma.

Jianling Ji1,2, Catherine Quindipan1, David Parham2,3, Lishuang Shen1, David Ruble1, Moiz Bootwalla1, Dennis T Maglinte1, Xiaowu Gai1,2, Sulagna C Saitta1,2, Jaclyn A Biegel1,2, Leo Mascarenhas4,3.   

Abstract

We report a family in which two brothers had an undiagnosed genetic disorder comprised of dysmorphic features, microcephaly, severe intellectual disability (non-verbal), mild anemia, and cryptorchidism. Both developed osteosarcoma. Trio exome sequencing (using blood samples from the younger brother and both parents) was performed and a nonsense NM_000489.4:c.7156C>T (p.Arg2386*) mutation in the ATRX gene was identified in the proband (hemizygous) and in the mother's peripheral blood DNA (heterozygous). The mother is healthy, does not exhibit any clinical manifestations of ATR-X syndrome and there was no family history of cancer. The same hemizygous pathogenic variant was confirmed in the affected older brother's skin tissue by subsequent Sanger sequencing. Chromosomal microarray studies of both brothers' osteosarcomas revealed complex copy number alterations consistent with the clinical diagnosis of osteosarcoma. Recently, somatic mutations in the ATRX gene have been observed as recurrent alterations in both osteosarcoma and brain tumors. However, it is unclear if there is any association between osteosarcoma and germline ATRX mutations, specifically in patients with constitutional ATR-X syndrome. This is the first report of osteosarcoma diagnosed in two males with ATR-X syndrome, suggesting a potential increased risk for cancer in patients with this disorder.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATR-X syndrome; cancer predisposition syndrome; chromosomal microarray; intellectual disability; osteosarcoma; tumor; whole exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28371217      PMCID: PMC7521841          DOI: 10.1002/ajmg.a.38184

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

1.  Molecular genetic study of japanese patients with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).

Authors:  T Wada; T Kubota; Y Fukushima; S Saitoh
Journal:  Am J Med Genet       Date:  2000-09-18

2.  Complex karyotypes in a series of pediatric osteosarcomas.

Authors:  J A Biegel; R B Womer; B S Emanuel
Journal:  Cancer Genet Cytogenet       Date:  1989-03

3.  ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.

Authors:  Benedikt Wiestler; David Capper; Tim Holland-Letz; Andrey Korshunov; Andreas von Deimling; Stefan Michael Pfister; Michael Platten; Michael Weller; Wolfgang Wick
Journal:  Acta Neuropathol       Date:  2013-08-01       Impact factor: 17.088

4.  Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.

Authors:  Jennifer A Perry; Adam Kiezun; Peter Tonzi; Eliezer M Van Allen; Scott L Carter; Sylvan C Baca; Glenn S Cowley; Ami S Bhatt; Esther Rheinbay; Chandra Sekhar Pedamallu; Elena Helman; Amaro Taylor-Weiner; Aaron McKenna; David S DeLuca; Michael S Lawrence; Lauren Ambrogio; Carrie Sougnez; Andrey Sivachenko; Loren D Walensky; Nikhil Wagle; Jaume Mora; Carmen de Torres; Cinzia Lavarino; Simone Dos Santos Aguiar; Jose Andres Yunes; Silvia Regina Brandalise; Gabriela Elisa Mercado-Celis; Jorge Melendez-Zajgla; Rocío Cárdenas-Cardós; Liliana Velasco-Hidalgo; Charles W M Roberts; Levi A Garraway; Carlos Rodriguez-Galindo; Stacey B Gabriel; Eric S Lander; Todd R Golub; Stuart H Orkin; Gad Getz; Katherine A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 5.  ATRX and the replication of structured DNA.

Authors:  David Clynes; Richard J Gibbons
Journal:  Curr Opin Genet Dev       Date:  2013-02-28       Impact factor: 5.578

6.  Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without alpha-thalassemia.

Authors:  L Villard; A Toutain; A M Lossi; J Gecz; C Houdayer; C Moraine; M Fontès
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).

Authors:  R J Gibbons; D J Picketts; L Villard; D R Higgs
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

Review 8.  The chromatin remodeller ATRX: a repeat offender in human disease.

Authors:  David Clynes; Douglas R Higgs; Richard J Gibbons
Journal:  Trends Biochem Sci       Date:  2013-08-01       Impact factor: 13.807

9.  At-risk populations for osteosarcoma: the syndromes and beyond.

Authors:  George T Calvert; R Lor Randall; Kevin B Jones; Lisa Cannon-Albright; Stephen Lessnick; Joshua D Schiffman
Journal:  Sarcoma       Date:  2012-03-12

10.  Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1.

Authors:  Roderick J O'Sullivan; Nausica Arnoult; Daniel H Lackner; Liana Oganesian; Candy Haggblom; Armelle Corpet; Genevieve Almouzni; Jan Karlseder
Journal:  Nat Struct Mol Biol       Date:  2014-01-12       Impact factor: 15.369

View more
  13 in total

1.  Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients.

Authors:  Julien Masliah-Planchon; Dominique Lévy; Delphine Héron; Fabienne Giuliano; Catherine Badens; Paul Fréneaux; Louise Galmiche; Jean-Marc Guinebretierre; Cécile Cellier; Joshua J Waterfall; Khadija Aït-Raïs; Gaëlle Pierron; Christophe Glorion; Isabelle Desguerre; Christine Soler; Anne Deville; Olivier Delattre; Jean Michon; Franck Bourdeaut
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

2.  Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

Authors:  Christian P Bradley; Cai Chen; Karolyn A Oetjen; Cheng Yan; Reema Panjwani; Sara Hauffe; Katherine R Calvo; Constance Yuan; Prapti Arvind Patel; Nathan D Montgomery; Matthew C Foster; Minoo Battiwalla; A John Barrett; Richard J Gibbons; Sawa Ito
Journal:  Blood Adv       Date:  2019-09-10

Review 3.  Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

Authors:  Xiaolei Ren; Chao Tu; Zhenchu Tang; Ruofei Ma; Zhihong Li
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

4.  Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.

Authors:  Lisa Mirabello; Bin Zhu; Roelof Koster; Eric Karlins; Michael Dean; Meredith Yeager; Matthew Gianferante; Logan G Spector; Lindsay M Morton; Danielle Karyadi; Leslie L Robison; Gregory T Armstrong; Smita Bhatia; Lei Song; Nathan Pankratz; Maisa Pinheiro; Julie M Gastier-Foster; Richard Gorlick; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patino-Garcia; Fernando Lecanda; Miriam Gutierrez-Jimeno; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Nilgün Kurucu; Inci Ergurhan Ilhan; Mandy L Ballinger; David M Thomas; Donald A Barkauskas; Gerardo Mejia-Baltodano; Patricia Valverde; Belynda D Hicks; Bin Zhu; Mingyi Wang; Amy A Hutchinson; Margaret Tucker; Joshua Sampson; Maria T Landi; Neal D Freedman; Susan Gapstur; Brian Carter; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  JAMA Oncol       Date:  2020-05-01       Impact factor: 31.777

Review 5.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.

Authors:  Maya Raghunandan; Jung Eun Yeo; Ryan Walter; Kai Saito; Adam J Harvey; Stacie Ittershagen; Eun-A Lee; Jihyeon Yang; Maureen E Hoatlin; Anja K Bielinsky; Eric A Hendrickson; Orlando Schärer; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

7.  Osteosarcoma in One of Identical Twins: Three Cases Report and a Literature Review.

Authors:  Jie Zhao; Wei Wang; Zhiyong Liu; Xiao Li; Qiqing Cai; Xiuchun Yu
Journal:  Orthop Surg       Date:  2021-05-05       Impact factor: 2.071

8.  Mutational spectrum of ATRX aberrations in neuroblastoma and associated patient and tumor characteristics.

Authors:  Michael R van Gerven; Eva Bozsaky; Yvette A H Matser; Julian Vosseberg; Sabine Taschner-Mandl; Jan Koster; Godelieve A M Tytgat; Jan J Molenaar; Marlinde van den Boogaard
Journal:  Cancer Sci       Date:  2022-04-26       Impact factor: 6.518

9.  G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.

Authors:  Yuxiang Wang; Jie Yang; Aaron T Wild; Wei H Wu; Rachna Shah; Carla Danussi; Gregory J Riggins; Kasthuri Kannan; Erik P Sulman; Timothy A Chan; Jason T Huse
Journal:  Nat Commun       Date:  2019-02-26       Impact factor: 14.919

10.  Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.

Authors:  Dan Liao; Li Zhong; Junqiang Yin; Cuiling Zeng; Xin Wang; Xingchuan Huang; Jinna Chen; Hong Zhang; Ruhua Zhang; Xin-Yuan Guan; Xintao Shuai; Jianhua Sui; Song Gao; Wuguo Deng; Yi-Xin Zeng; Jing-Nan Shen; Jian Chen; Tiebang Kang
Journal:  Nat Cell Biol       Date:  2020-06-01       Impact factor: 28.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.